West Pharmaceutical Services, Inc. WST
401.01 USD -3.01 (-0.75%)
As ofNov 19, 2026, 11:45 AM EST
396.27 Day range 406.96
230.95 52-week range 417.80
- YTD
- +45.75%
- 1 year
- +55.49%
Benzinga news
benzinga.com Citigroup Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $494 Citigroup analyst Joanne Wuensch maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $412 to $494.
benzinga.com TD Cowen Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $500 TD Cowen analyst Brendan Smith maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $420 to $500.
benzinga.com Barclays Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $500 Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and raises the price target from $440 to $500.
benzinga.com Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $480 Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the price target from $440 to $480.
benzinga.com West Pharmaceutical Servs Q3 2026 Earnings Call Transcript West Pharmaceutical Servs (NYSE:WST) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…benzinga.com West Pharmaceutical Servs Sees Q4 Adj EPS $2.22-$2.32 vs $2.27 Est; Sees Sales $820.000M-$830.000M vs $826.736M Est West Pharmaceutical Servs (NYSE:WST) is looking for Q4 Adj EPS of $2.22-$2.32 vs $2.27 analyst estimate. sees sales of $820.000 million-$830.000 million vs $826.736 million analyst estimate.
benzinga.com West Pharmaceutical Servs Q3 Adj. EPS $2.66 Beats $2.19 Estimate, Sales $874.500M Beat $825.700M Estimate West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.66 per share which beat the analyst consensus estimate of $2.19 by 21.46 percent. This is a 35.71 percent increase over earnings…
benzinga.com West Pharmaceutical Servs Raises FY2026 GAAP EPS Guidance from $9.01-$9.26 to $9.31-$9.41 vs $8.47 Est West Pharmaceutical Servs (NYSE:WST) raises FY2026 GAAP EPS guidance from $9.01-$9.26 to $9.31-$9.41 vs $8.47 analyst estimate..
benzinga.com This 146-Old Can Maker Is On a Winning Streak Unseen In Its Half-Century Stock History Ball Corp stock is on an 11-day winning streak, its longest since NYSE trading began in 1973, while the S&P 500 has slipped. Here is what the data shows.
